Drug:
Reaction: THROMBOCYTOPENIA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26527921 |
EU |
2 | |
Thrombocytopenia, Foetal exposure during pregnancy, |
||||
HUMAN IMMUNOGLOBULIN G, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 102 | 26528034 |
IN |
63 | 2 |
Off label use, Thrombocytopenia, Hyperbilirubinaemia, Fall, Injury, Compression fracture, |
||||
ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, LAPATINIB, CARVEDILOL, ALUMINA, MAGNESIA, SIMETHICONE, LORAZEPAM, URSODIOL, URSOSIOL, |
||||
| 103 | 26528085 |
EU |
62 | 1 |
Minimal residual disease, Lymphocytosis, Thrombocytopenia, |
||||
VENETOCLAX, ACALABRUTINIB, |
||||
| 104 | 26528390 |
US |
18 | 1 |
Toxicity to various agents, Mental status changes, Unresponsive to stimuli, Urinary incontinence, Dysarthria, Incoherent, Vomiting, Electrolyte imbalance, Acute kidney injury, Blood creatinine increased, Thrombocytopenia, Hyponatraemia, |
||||
LITHIUM, LITHIUM BROMATUM, |
||||
| 105 | 26528600 |
CN |
||
Neutropenia, Anaemia, Leukopenia, Thrombocytopenia, Transaminases increased, Blood creatinine increased, Fatigue, Nausea, Vomiting, Diarrhoea, Constipation, Pneumonia, Hypothyroidism, Hyperthyroidism, Rash, Adrenal insufficiency, |
||||
ATEZOLIZUMAB, DURVALUMAB, ETOPOSIDE, CARBOPLATIN, CISPLATIN, |
||||
| 106 | 26528615 |
EG |
45 | 2 |
Thrombocytopenia, Haematuria, Acute kidney injury, Hypoalbuminaemia, Hypocalcaemia, General physical health deterioration, Normochromic normocytic anaemia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, FENTANYL, FENTANYL, FENTANYL, FENTANYL, |
||||
| 107 | 26528663 |
EU |
2 | |
Thrombocytopenia, Coagulopathy, |
||||
OFATUMUMAB, |
||||
| 108 | 26528668 |
US |
||
Thrombocytopenia, |
||||
MITOMYCIN, |
||||
| 109 | 26528731 |
CN |
70 | 2 |
Acute respiratory failure, Pneumonia, Myelosuppression, Aspergillus infection, Influenza, Leukopenia, Thrombocytopenia, Product use in unapproved indication, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, POLATUZUMAB VEDOTIN, BENDAMUSTINE HCL, |
||||
| 110 | 26529071 |
GB |
1 | |
Thrombocytopenia, Differential white blood cell count abnormal, |
||||
CLOZAPINE, |
||||
| 111 | 26529130 |
EU |
75 | 2 |
Neutropenia, Thrombocytopenia, Anaemia, |
||||
LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 112 | 26529425 |
US |
64 | 1 |
Mucormycosis, Liver disorder, Drug ineffective for unapproved indication, Leukocytosis, Thrombocytopenia, Hypertransaminasaemia, Acute kidney injury, Haemorrhage, Hepatic artery aneurysm, Intestinal ischaemia, Hepatic necrosis, Slow response to stimuli, Hypothermia, Respiratory failure, Hyperbilirubinaemia, Product prescribing issue, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, DAPTOMYCIN, DAPTOMYCIN, DAPTOMYCIN, DAPTOMYCIN, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, MEROPENEM, MEROPENEM, MEROPENEM, MEROPENEM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 113 | 26529558 |
EU |
48 | 2 |
Thrombocytopenia, Neutropenia, Hepatitis, Mucosal inflammation, Radiation skin injury, Oesophagitis, Lymphopenia, Off label use, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 114 | 26529854 |
EU |
72 | 2 |
Immune-mediated enterocolitis, Cutaneous vasculitis, Malignant neoplasm progression, Thrombocytopenia, Drug hypersensitivity, |
||||
PEMETREXED, PEMETREXED DISODIUM, NIVOLUMAB, IPILIMUMAB, CARBOPLATIN, |
||||
| 115 | 26529926 |
EU |
81 | 2 |
Sepsis, Thrombocytopenia, |
||||
TRIFLURIDINE AND TIPIRACIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EXEMESTANE, FOLIC ACID, |
||||
| 116 | 26530215 |
US |
2 | |
Thrombocytopenia, |
||||
NIRAPARIB, |
||||
| 117 | 26530442 |
TW |
||
Neutropenia, Sepsis, Thrombocytopenia, Cytokine release syndrome, Pneumonia, Pneumocystis jirovecii infection, Neuropathy peripheral, Hepatotoxicity, Hypogammaglobulinaemia, Immune effector cell-associated neurotoxicity syndrome, Febrile neutropenia, Anaemia, Cytomegalovirus infection, Herpes zoster, Influenza, COVID-19, Headache, Fatigue, |
||||
| 118 | 26530629 |
EU |
62 | 1 |
Thrombocytopenia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, DARATUMUMAB, THALIDOMIDE, MELPHALAN HYDROCHLORIDE, MELPHALAN, |
||||
| 119 | 26530707 |
EU |
1 | |
Thrombocytopenia, Foetal exposure during pregnancy, Off label use, |
||||
| 120 | 26530708 |
EU |
1 | |
Thrombocytopenia, Foetal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 121 | 26530755 |
CN |
35 | 2 |
Thrombocytopenia, Neutropenia, Cytokine release syndrome, Anaemia, Off label use, |
||||
CARFILZOMIB, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, |
||||
| 122 | 26522579 |
CN |
11 | 1 |
Purtscher retinopathy, Retinal haemorrhage, Blindness, Cystoid macular oedema, Metamorphopsia, Retinal exudates, Retinal deposits, Macular oedema, Retinal ischaemia, Optic disc oedema, Visual acuity reduced, Papilloedema, Thrombotic microangiopathy, Thrombocytopenia, Proteinuria, Renal impairment, Effusion, Vitreous opacities, H1N1 influenza, Influenza, Adenovirus infection, Human herpesvirus 6 infection, Endothelial dysfunction, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, INOTUZUMAB OZOGAMICIN, BELIMUMAB, BELIMUMAB, BELIMUMAB, BELIMUMAB, ETOPOSIDE, CLADRIBINE, CYTARABINE, CYCLOSPORINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 123 | 26522587 |
CN |
53 | 1 |
Anaemia, Thrombocytopenia, Neutropenia, Pneumonia, Acute graft versus host disease in skin, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, CLADRIBINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 124 | 26522603 |
CN |
27 | 1 |
Anaemia, Thrombocytopenia, Neutropenia, Enteritis infectious, Acute graft versus host disease in intestine, Acute graft versus host disease in skin, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VENETOCLAX, VENETOCLAX, |
||||
| 125 | 26522691 |
JP |
54 | 1 |
Macular oedema, Diarrhoea, Tinnitus, Deafness neurosensory, Acute kidney injury, Pancytopenia, Febrile neutropenia, Thrombocytopenia, Photophobia, Peripheral sensory neuropathy, Myelosuppression, Vision blurred, Drug-induced liver injury, |
||||
CISPLATIN, CARBOPLATIN, HEPARIN SODIUM, ETOPOSIDE, |
||||
| 126 | 26523006 |
CN |
||
Thrombocytopenia, Anaemia, Neutropenia, Febrile neutropenia, Pneumonia, Neurotoxicity, Tumour lysis syndrome, |
||||
RITUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
| 127 | 26523426 |
EU |
17 | 1 |
Lower gastrointestinal haemorrhage, Thrombocytopenia, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, |
||||
| 128 | 26523478 |
EU |
1 | |
Thrombocytopenia, |
||||
ENZALUTAMIDE, TALAZOPARIB, |
||||
| 129 | 26523495 |
CN |
63 | 1 |
Respiratory failure, Shock haemorrhagic, Myelosuppression, Pneumonia, Pyrexia, Haemorrhagic diathesis, Thrombocytopenia, |
||||
CYTARABINE, ETOPOSIDE, |
||||
| 130 | 26523593 |
KR |
86 | 2 |
Thrombocytopenia, Off label use, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 131 | 26523610 |
KR |
76 | 2 |
Thrombocytopenia, Off label use, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 132 | 26523680 |
EU |
87 | 2 |
Thrombocytopenia, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, APIXABAN, |
||||
| 133 | 26523821 |
JP |
||
Hepatic function abnormal, Stomatitis, Neutropenia, Thrombocytopenia, Febrile neutropenia, Infection, Renal impairment, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 134 | 26523951 |
EU |
77 | 2 |
Neutropenia, Anaphylactic shock, Somnolence, Thrombocytopenia, Asthenia, |
||||
PEMBROLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 135 | 26524086 |
US |
71 | 2 |
Thrombotic microangiopathy, Acute kidney injury, Thrombocytopenia, |
||||
POMALIDOMIDE, POMALIDOMIDE, CARFILZOMIB, GABAPENTIN, |
||||
| 136 | 26524182 |
CN |
||
Septic shock, Leukopenia, Neutropenia, Pneumonia, COVID-19, Thrombocytopenia, Gastrointestinal infection, Skin infection, Soft tissue infection, Oral infection, Atrial fibrillation, Haemorrhage, Epstein-Barr viraemia, |
||||
RITUXIMAB, ZANUBRUTINIB, BENDAMUSTINE HCL, |
||||
| 137 | 26524358 |
US |
87 | 1 |
Drug interaction, Drug clearance decreased, Thrombocytopenia, Stomatitis, Epistaxis, Anaemia, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FUROSEMIDE, |
||||
| 138 | 26524435 |
US |
57 | 2 |
Pyrexia, Liver injury, Vomiting, Diarrhoea, Abdominal discomfort, Acute kidney injury, Hypotension, Leukopenia, Thrombocytopenia, Hyperpyrexia, |
||||
DABRAFENIB, TRAMETINIB, |
||||
| 139 | 26524472 |
EU |
50 | 2 |
Cardiogenic shock, Pancytopenia, Drug ineffective, Myelosuppression, Thrombocytopenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, DOBUTAMINE, METHYLPREDNISOLONE, |
||||
| 140 | 26524779 |
65 | 1 | |
Pericardial effusion, Bone marrow failure, Cardiorenal syndrome, Hypertension, Malignant neoplasm progression, Enterococcal infection, Urinary tract infection, Thrombocytopenia, Anaemia, Thrombotic microangiopathy, |
||||
PACLITAXEL, FUROSEMIDE, |
||||
| 141 | 26524826 |
US |
87 | 1 |
Thrombocytopenia, Stomatitis, Epistaxis, Anaemia, Drug clearance decreased, Drug interaction, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FUROSEMIDE, |
||||
| 142 | 26524889 |
CN |
||
Pulmonary toxicity, Anaemia, Neutropenia, Thrombocytopenia, Hepatotoxicity, Gastrointestinal disorder, Infection, Pneumonia, Cardiovascular disorder, Neurotoxicity, Rash, Hypersensitivity, Nephropathy toxic, |
||||
RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TEMOZOLOMIDE, |
||||
| 143 | 26525452 |
PR |
72 | 1 |
Leukopenia, Normocytic anaemia, Thrombocytopenia, Lactic acidosis, Neutropenic colitis, Lower gastrointestinal haemorrhage, Septic shock, Pseudomonas infection, Escherichia infection, Off label use, |
||||
CAPECITABINE, CAPECITABINE, CAPECITABINE, |
||||
| 144 | 26525534 |
CA |
17 | 2 |
Aplastic anaemia, Febrile neutropenia, Mucosal inflammation, Thrombocytopenia, |
||||
ETOPOSIDE, |
||||
| 145 | 26525593 |
EU |
73 | 1 |
Thrombocytopenia, |
||||
BORTEZOMIB, BORTEZOMIB, SELINEXOR, SELINEXOR, SELINEXOR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ZOLEDRONIC ACID, OLANZAPINE, OLANZAPINE, |
||||
| 146 | 26525687 |
US |
||
Thrombocytopenia, Weight decreased, Hair texture abnormal, Arthralgia, Hypoaesthesia, Anaemia, Pain in extremity, |
||||
ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CYCLOSPORINE, ERYTHROMYCIN, GABAPENTIN, LORAZEPAM, PREDNISONE, OMEPRAZOLE MAGNESIUM, CYCLOSPORINE, VORICONAZOLE, |
||||
| 147 | 26526264 |
EU |
78 | 1 |
Thrombocytopenia, |
||||
NIVOLUMAB, |
||||
| 148 | 26526297 |
EU |
83 | 2 |
Thrombocytopenia, Productive cough, Anaemia, |
||||
PREDNISONE, POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, LAMIVUDINE, LAMIVUDINE ORAL, ACYCLOVIR, TRIMETHOPRIM, ALLOPURINOL, |
||||
| 149 | 26526477 |
ZA |
2 | |
Thrombocytopenia, Suicidal behaviour, Anaemia, |
||||
OLAPARIB, |
||||
| 150 | 26522034 |
EU |
62 | 1 |
Diffuse large B-cell lymphoma recurrent, Acute hepatic failure, Thrombocytopenia, Haemophagocytic lymphohistiocytosis, |
||||
OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GLOFITAMAB, LENALIDOMIDE, |
||||
| 151 | 26522104 |
EU |
50 | 1 |
Leukopenia, Thrombocytopenia, Anaemia, |
||||
LACOSAMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LOMUSTINE, LOMUSTINE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, CARBAMAZEPINE, CENOBAMATE, |
||||
| 152 | 26522333 |
KR |
76 | 2 |
Thrombocytopenia, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 153 | 26522545 |
CN |
31 | 1 |
Neutropenia, Anaemia, Thrombocytopenia, Pneumonia, Enteritis infectious, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 154 | 26521141 |
CN |
||
Pancytopenia, Thrombocytopenia, Anaemia, |
||||
LINEZOLID, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BUDESONIDE, |
||||
| 155 | 26521169 |
CH |
51 | 1 |
Pancytopenia, Neutropenia, Anaemia, Thrombocytopenia, |
||||
DAPTOMYCIN, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, FOLIC ACID, ASCORBIC ACID, THIAMINE HYDROCHLORIDE, CYANOCOBALAMIN, POTASSIUM PHOSPHATE, DIBASIC, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 156 | 26521735 |
EU |
1 | |
Thrombocytopenia, Foetal exposure during pregnancy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 157 | 26517028 |
US |
87 | 1 |
Systemic toxicity, Thrombocytopenia, Bicytopenia, Mucosal inflammation, Oral mucosa erosion, Oropharyngeal pain, Mouth ulceration, Epistaxis, Anaemia, Fatigue, Malaise, Drug interaction, Drug clearance decreased, Drug level increased, |
||||
FUROSEMIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 158 | 26517117 |
SA |
60 | 1 |
Oesophageal achalasia, Nephritis, Ureteritis, Adenovirus infection, Thrombocytopenia, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, WARFARIN, |
||||
| 159 | 26517127 |
SA |
60 | 1 |
Adenovirus infection, Oesophageal achalasia, Thrombocytopenia, Nephritis, Ureteritis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, WARFARIN, |
||||
| 160 | 26517757 |
KR |
60 | 1 |
Herpes zoster, Optic neuritis, Thrombocytopenia, Depressed level of consciousness, Seizure, Varicella zoster virus infection, Viral vasculitis, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CARBOPLATIN, BENDAMUSTINE HYDROCHLORIDE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POLATUZUMAB VEDOTIN, IFOSFAMIDE, ETOPOSIDE, PREDNISONE, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, ETOPOSIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 161 | 26517782 |
EU |
47 | 2 |
Thrombocytopenia, |
||||
QUETIAPINE, DIVALPROEX SODIUM, |
||||
| 162 | 26518101 |
CN |
70 | 2 |
Aspergillus infection, Influenza, Thrombocytopenia, Leukopenia, Myelosuppression, Pneumonia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, RITUXIMAB, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, |
||||
| 163 | 26518417 |
US |
31 | 2 |
Contusion, Intermenstrual bleeding, Thrombocytopenia, Impaired healing, Product use in unapproved indication, |
||||
EVEROLIMUS, |
||||
| 164 | 26518420 |
EU |
87 | 2 |
Thrombocytopenia, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, APIXABAN, |
||||
| 165 | 26518456 |
JP |
79 | 2 |
Malignant neoplasm progression, Pain of skin, Hypertension, Stomatitis, Dysphonia, Thrombocytopenia, Blood thyroid stimulating hormone increased, Arthralgia, Somnolence, Rash, Decreased appetite, Pyrexia, Malaise, Nausea, Diarrhoea, Vomiting, Thrombocytopenia, Hypothyroidism, Myocarditis, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, |
||||
| 166 | 26518459 |
TR |
59 | 2 |
Anaemia, Thrombocytopenia, Neutropenia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, DENOSUMAB, |
||||
| 167 | 26518482 |
CO |
48 | 1 |
Thrombocytopenia, Pulmonary oedema, Pneumonia, White blood cell count increased, Infection, |
||||
ACALABRUTINIB, |
||||
| 168 | 26518727 |
US |
||
Thrombocytopenia, |
||||
LINEZOLID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, |
||||
| 169 | 26519225 |
56 | 1 | |
Thrombocytopenia, |
||||
DAROLUTAMIDE, DAROLUTAMIDE, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 170 | 26519783 |
CN |
70 | 2 |
Myelosuppression, Leukopenia, Pneumonia, Aspergillus infection, Influenza, Acute respiratory failure, Diffuse large B-cell lymphoma refractory, Thrombocytopenia, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, POLATUZUMAB VEDOTIN, PREDNISONE, RITUXIMAB, BENDAMUSTINE HCL, |
||||
| 171 | 26520104 |
US |
||
Thrombocytopenia, Fatigue, Nausea, Diarrhoea, Constipation, Pain, Dermatitis, Rash, Neuropathy peripheral, Colitis, Cytopenia, Neutropenia, Anaemia, Hypertransaminasaemia, Hyperbilirubinaemia, Pneumonitis, |
||||
CAPECITABINE, TRASTUZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, DURVALUMAB, PERTUZUMAB, CISPLATIN, NERATINIB, LENVATINIB, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 172 | 26520105 |
US |
49 | 1 |
Product prescribing error, Gout, Circumstance or information capable of leading to medication error, Off label use, Nephrogenic anaemia, Hypertension, Hyperparathyroidism secondary, Metabolic acidosis, Immunosuppression, Renovascular hypertension, Thrombocytopenia, Vitamin D deficiency, Hyperuricaemia, Blood pressure increased, Focal segmental glomerulosclerosis, Arteriovenous fistula site pseudoaneurysm, Thrombophlebitis, Renal impairment, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ALLOPURINOL, CINACALCET, CYCLOSPORINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LOSARTAN, PREDNISONE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 173 | 26520279 |
EU |
78 | 2 |
Febrile neutropenia, Enterococcal bacteraemia, Thrombocytopenia, Renal failure, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
| 174 | 26520347 |
CN |
||
Leukopenia, Neutropenia, Thrombocytopenia, Pneumonia, Intestinal obstruction, Lymphopenia, Anaemia, Off label use, Upper respiratory tract infection, Herpes zoster, Diarrhoea, Oedema peripheral, Peripheral sensory neuropathy, Infusion related reaction, |
||||
DARATUMUMAB, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 175 | 26520404 |
48 | 2 | |
Thrombocytopenia, Acute lymphocytic leukaemia, Device use issue, |
||||
LEVONORGESTREL, LEVONORGESTREL, |
||||
| 176 | 26520477 |
EU |
75 | 1 |
Thrombocytopenia, |
||||
AXITINIB, ESOMEPRAZOLE SODIUM, PEMBROLIZUMAB, EZETIMIBE, |
||||
| 177 | 26520504 |
CA |
85 | 1 |
Leukopenia, Thrombocytopenia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROXYUREA, |
||||
| 178 | 26524063 |
50 | 1 | |
Contusion, Thrombocytopenia, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, AMLODIPINE, HYDROCHLOROTHIAZIDE, LOSARTAN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 179 | 26512221 |
US |
||
Hyperglycaemia, Sepsis, Urinary tract infection, Encephalitis, Pneumonia, Neutropenia, Off label use, Anaemia, Colitis, Thrombocytopenia, Lymphopenia, |
||||
IBRUTINIB, |
||||
| 180 | 26512577 |
PR |
72 | 1 |
Normocytic anaemia, Thrombocytopenia, Lactic acidosis, Neutropenic colitis, Lower gastrointestinal haemorrhage, Septic shock, Pseudomonas infection, Escherichia infection, |
||||
CAPECITABINE, CAPECITABINE, CAPECITABINE, |
||||
| 181 | 26512866 |
EU |
||
Fatigue, Hypertension, Decreased appetite, Weight decreased, Diarrhoea, Pruritus, Pyrexia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Abdominal pain, Thrombocytopenia, Hypothyroidism, Proteinuria, Anaemia, Nausea, Vomiting, Epistaxis, Rash, Mucosal inflammation, Gastrointestinal haemorrhage, Haemorrhage, Intestinal varices haemorrhage, Embolism venous, Haemorrhoidal haemorrhage, Leukopenia, Arthralgia, Dysphonia, Embolism arterial, Hyperthyroidism, Immune-mediated enterocolitis, Dysgeusia, Skin ulcer, Immune-mediated lung disease, Palmar-plantar erythrodysaesthesia syndrome, Immune-mediated hepatitis, Cardiac failure, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 182 | 26512967 |
RU |
60 | 2 |
Thrombocytopenia, Thrombocytopenic purpura, Condition aggravated, |
||||
NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE, |
||||
| 183 | 26513148 |
53 | 2 | |
Necrotising fasciitis, Neutropenia, Multiple organ dysfunction syndrome, Thrombocytopenia, Septic shock, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 184 | 26513649 |
EU |
70 | 2 |
Gamma-glutamyltransferase increased, Thrombocytopenia, |
||||
IRINOTECAN HYDROCHLORIDE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 185 | 26514400 |
EU |
76 | 1 |
Disseminated intravascular coagulation, Thrombocytopenia, |
||||
TOCILIZUMAB, |
||||
| 186 | 26514907 |
US |
||
Thrombocytopenia, Cytokine release syndrome, Pulmonary haemorrhage, |
||||
TALQUETAMAB, |
||||
| 187 | 26514980 |
EU |
40 | 2 |
Thrombocytopenia, Lymphadenopathy, Weight increased, Headache, Haemoglobin decreased, Psoriasis, Red blood cell sedimentation rate increased, Drug intolerance, Skin disorder, Drug ineffective, |
||||
METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ABATACEPT, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, AMLODIPINE, BARICITINIB, |
||||
| 188 | 26515098 |
EU |
19 | 1 |
Thrombocytopenia, Respiratory syncytial virus infection, Nasopharyngitis, Pyrexia, Drug ineffective, |
||||
NIRSEVIMAB, |
||||
| 189 | 26515203 |
US |
64 | 1 |
Neutropenia, Thrombocytopenia, Hypertransaminasaemia, Mucosal inflammation, |
||||
METHOTREXATE SODIUM, RITUXIMAB, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 190 | 26515425 |
US |
87 | 1 |
Thrombocytopenia, Drug interaction, Drug clearance decreased, Off label use, Stomatitis, Epistaxis, Anaemia, Fatigue, Malaise, |
||||
METHOTREXATE SODIUM, FUROSEMIDE, |
||||
| 191 | 26515516 |
83 | 2 | |
Delayed haemolytic transfusion reaction, Haemolysis, Haptoglobin decreased, Haemoglobin decreased, Thrombocytopenia, |
||||
| 192 | 26515884 |
CA |
1 | |
Thrombocytopenia, Myelosuppression, |
||||
DURVALUMAB, |
||||
| 193 | 26516606 |
EU |
73 | 1 |
Thrombocytopenia, Off label use, Drug effective for unapproved indication, |
||||
BORTEZOMIB, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, LENALIDOMIDE, SELINEXOR, SELINEXOR, SELINEXOR, ZOLEDRONIC ACID, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, OLANZAPINE, |
||||
| 194 | 26508302 |
EU |
60 | 1 |
Thrombocytopenia, Haemoglobin increased, Haematocrit increased, Blood bilirubin increased, Ventricular tachycardia, Ventricular fibrillation, Torsade de pointes, Ventricular tachycardia, Ventricular tachycardia, Atrial tachycardia, Palpitations, Supraventricular tachycardia, Left ventricular dysfunction, Ventricular hypokinesia, Aneurysm, Aortic dilatation, Constipation, Anal haemorrhage, |
||||
DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, SPIRONOLACTONE, TELMISARTAN, |
||||
| 195 | 26508415 |
CN |
||
Nausea, Vomiting, Liver injury, Myelosuppression, Thrombocytopenia, Leukopenia, Renal injury, |
||||
CAPECITABINE, TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, |
||||
| 196 | 26508438 |
EG |
49 | 1 |
Thrombocytopenia, White blood cell count increased, Haemoglobin decreased, Klebsiella infection, Hepatic enzyme increased, |
||||
ENOXAPARIN SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 197 | 26508775 |
EU |
52 | 2 |
Thrombocytopenia, Off label use, |
||||
ECULIZUMAB, PREDNISONE, |
||||
| 198 | 26509214 |
US |
||
Hypotension, Thrombocytopenia, Diarrhoea, Infusion related reaction, Dehydration, Cough, Vaginal haemorrhage, Aspartate aminotransferase increased, Heavy menstrual bleeding, Neutrophil count decreased, Dizziness, Dysphagia, Blood creatinine increased, Blood alkaline phosphatase increased, Blood lactate dehydrogenase increased, Arthropod bite, Hyponatraemia, Dysgeusia, Petechiae, |
||||
BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, BELINOSTAT, TAZEMETOSTAT, TAZEMETOSTAT, TAZEMETOSTAT, TAZEMETOSTAT, |
||||
| 199 | 26509294 |
US |
26 | 2 |
Thrombocytopenia, Foetal disorder, Maternal exposure during pregnancy, Gestational hypertension, Live birth, Perineal injury, |
||||
PREDNISONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FILGRASTIM, FILGRASTIM, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 200 | 26509411 |
EU |
||
COVID-19, Generalised tonic-clonic seizure, Thrombocytopenia, Anaemia, Dizziness, Vestibular disorder, |
||||
LINEZOLID, AMIKACIN, AMIKACIN, COLCHICINE, PREDNISONE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
